oncodaily - A major international clinical trial, NRG-LU005, has provided important new insight into how immunotherapy should be used in limited-stage small cell lung cancer (SCLC). While immune checkpoint inhibitors have significantly […]
#healthcare #pharmaceuticals #biotech #drugdevelopment #oncology #cancerresearch
Monday, March 16, 2026, 12:23 am / permalink 20789 / 4 stories in 18 hrs
HIMSS 2026 pushes real‑time data, cloud and interoperability playbook (14 hrs)
Neoadjuvant GOLP improves event‑free survival in high‑risk intrahepatic cholangiocarcinoma (15 hrs)
Vitamin D trial shows reduced long‑COVID risk but no severity benefit (17 hrs)
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.